Metformin Mitigates Fibrosis and Glucose Intolerance Induced by Doxorubicin in Subcutaneous Adipose Tissue
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin Mitigates Fibrosis and Glucose Intolerance Induced by Doxorubicin in Subcutaneous Adipose Tissue
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-08
DOI
10.3389/fphar.2018.00452
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults
- (2018) Ameya S Kulkarni et al. AGING CELL
- DNA Damage and the Activation of the p53 Pathway Mediate Alterations in Metabolic and Secretory Functions of Adipocytes
- (2016) Bastien Vergoni et al. DIABETES
- AMPK Activation by Metformin Suppresses Abnormal Extracellular Matrix Remodeling in Adipose Tissue and Ameliorates Insulin Resistance in Obesity
- (2016) Ting Luo et al. DIABETES
- LPS Induces Hyper-Permeability of Intestinal Epithelial Cells
- (2016) Amir Bein et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Metformin inhibits aldosterone-induced cardiac fibroblast activation, migration and proliferation in vitro, and reverses aldosterone+salt-induced cardiac fibrosis in vivo
- (2016) Srinivas Mummidi et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Impact of Doxorubicin Treatment on the Physiological Functions of White Adipose Tissue
- (2016) Luana Amorim Biondo et al. PLoS One
- Mechanisms of Doxorubicin Toxicity in Pancreatic β-Cells
- (2016) Emma A. Heart et al. TOXICOLOGICAL SCIENCES
- Improving treatment and liver fibrosis outcomes with metformin in HCV-HIV co-infected and HCV mono-infected patients with insulin resistance: study protocol for a randomized controlled trial
- (2016) Mary-Anne Doyle et al. Trials
- Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a
- (2016) Zhan Sun et al. Experimental and Therapeutic Medicine
- Doxorubicin caused severe hyperglycaemia and insulin resistance, mediated by inhibition in AMPk signalling in skeletal muscle
- (2016) Edson Alves de Lima Junior et al. Journal of Cachexia Sarcopenia and Muscle
- Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients
- (2016) Iris J.G. Rutten et al. Journal of Cachexia Sarcopenia and Muscle
- Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders
- (2016) Sung Sik Choe et al. Frontiers in Endocrinology
- Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial
- (2015) Sirwan M. Hadad et al. BREAST CANCER RESEARCH AND TREATMENT
- Inter-relationships of the chronobiotic, melatonin, with leptin and adiponectin: implications for obesity
- (2015) Karolina Szewczyk-Golec et al. JOURNAL OF PINEAL RESEARCH
- Activation of AMPK by metformin inhibits TGF-β-induced collagen production in mouse renal fibroblasts
- (2015) Jiamei Lu et al. LIFE SCIENCES
- Potential Biomarkers of Fat Loss as a Feature of Cancer Cachexia
- (2015) Maryam Ebadi et al. MEDIATORS OF INFLAMMATION
- Nonmuscle Tissues Contribution to Cancer Cachexia
- (2015) Josep M. Argilés et al. MEDIATORS OF INFLAMMATION
- Fibrosis — A Common Pathway to Organ Injury and Failure
- (2015) Don C. Rockey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oxidative/Nitrative Stress and Inflammation Drive Progression of Doxorubicin-Induced Renal Fibrosis in Rats as Revealed by Comparing a Normal and a Fibrosis-Resistant Rat Strain
- (2015) Csaba Imre Szalay et al. PLoS One
- Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
- (2015) Luc Rochette et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Metformin Protects Cardiomyocyte from Doxorubicin Induced Cytotoxicity through an AMP-Activated Protein Kinase Dependent Signaling Pathway: An In Vitro Study
- (2014) Laura C. Kobashigawa et al. PLoS One
- Evidence and Mechanisms of Fat Depletion in Cancer
- (2014) Maryam Ebadi et al. Nutrients
- Metformin Regulates Glucose Transporter 4 (GLUT4) Translocation through AMP-activated Protein Kinase (AMPK)-mediated Cbl/CAP Signaling in 3T3-L1 Preadipocyte Cells
- (2012) Jung Ok Lee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Toll-Like Receptor (TLR) 2 and TLR4 Differentially Regulate Doxorubicin Induced Cardiomyopathy in Mice
- (2012) Yonggang Ma et al. PLoS One
- The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity
- (2012) Christian Henninger et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- TLR-2 and TLR-9 are sensors of apoptosis in a mouse model of doxorubicin-induced acute inflammation
- (2011) D V Krysko et al. CELL DEATH AND DIFFERENTIATION
- Cellular and molecular mechanisms of metformin: an overview
- (2011) Benoit Viollet et al. CLINICAL SCIENCE
- Architecture and the extracellular matrix: the still unappreciated components of the adipose tissue
- (2011) A. Divoux et al. Obesity Reviews
- Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial
- (2010) K. Hosono et al. Cancer Prevention Research
- Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
- (2010) Simon A. Hawley et al. Cell Metabolism
- Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
- (2009) G. W.D. Landman et al. DIABETES CARE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started